Author Question: Jane has a job interview this morning. She hasn't worked for a year, as she was seeking treatment ... (Read 73 times)

amal

  • Hero Member
  • *****
  • Posts: 572
Jane has a job interview this morning. She hasn't worked for a year, as she was seeking treatment for depression and was unable to meet the demands of employment.
 
  Jane also has limitations on what she can do in the workplace due to partial blindness in one eye. If the interviewer were to discriminate against Jane, which factor is the most likely one to be an issue?
 
  a) Jane's gender (female)
  b) Jane's physical disability
  c) Jane's mental illness
  d) Jane's gap in employment history

Question 2

In Canada, matters of health law are determined at the ____________ level
 
  a) Federal
  b) Provincial
  c) Municipal
  d) Civil



rnehls

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

c

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library